Composition
- Active ingredients
- GADOVERSETAMIDE 4963.5MG/15ML (330.9MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GADOVERSETAMIDE 4963.5MG/15ML (330.9MG/ML) · InjectableThis page
- GADOVERSETAMIDE 1654.5MG/5ML (330.9MG/ML) · InjectableNDA020937-001 · Discontinued
- GADOVERSETAMIDE 6618MG/20ML (330.9MG/ML) · InjectableNDA020937-004 · Discontinued
- GADOVERSETAMIDE 3309MG/10ML (330.9MG/ML) · InjectableNDA020937-002 · Discontinued
- GADOVERSETAMIDE 16.545GM/50ML (330.9MG/ML) · InjectableNDA020975-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020937.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Optimark
- Active substance
- gadoversetamide
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Liebel-Flarsheim
- Status
- Discontinued
- FDA approval
- 8 Dec 1999
- Application
- NDA020937-003